2-naphthoylethyltrimethylammonium has been researched along with wortmannin in 1 studies
Studies (2-naphthoylethyltrimethylammonium) | Trials (2-naphthoylethyltrimethylammonium) | Recent Studies (post-2010) (2-naphthoylethyltrimethylammonium) | Studies (wortmannin) | Trials (wortmannin) | Recent Studies (post-2010) (wortmannin) |
---|---|---|---|---|---|
13 | 0 | 9 | 4,066 | 2 | 726 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Chen, J; Huang, B; Huang, C; Li, M; Niu, J; Ren, L; Wang, B; Wu, L; Xiang, L; Xiao, T; Zhang, JV; Zhao, H | 1 |
1 other study(ies) available for 2-naphthoylethyltrimethylammonium and wortmannin
Article | Year |
---|---|
CMKLR1 deficiency attenuates androgen-induced lipid accumulation in mice.
Topics: Adipocytes; Adipose Tissue, Brown; Androgens; Animals; Body Weight; Cell Size; Dihydrotestosterone; Female; Lipid Metabolism; Male; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Mice, Knockout; Naphthalenes; Phosphatidylinositol 3-Kinases; Protein Kinase Inhibitors; Quaternary Ammonium Compounds; Receptors, Chemokine; Wortmannin | 2020 |